Advances in the treatment of neurofibromatosis-associated tumours.
about
A critical role for NF2 and the Hippo pathway in branching morphogenesisGenome-scale CRISPR-Cas9 knockout screening in human cellsNeurofibromatoses: part 1 - diagnosis and differential diagnosis.Triterpenoid saponin flaccidoside II from Anemone flaccida triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors via the MAPK-HO-1 pathwayThe role of nerve microenvironment for neurofibroma development.The impact of germline mutations on targeted therapy.A 3D-Engineered Conformal Implant Releases DNA Nanocomplexs for Eradicating the Postsurgery Residual Glioblastoma.CNS Tumors in Neurofibromatosis.Immortalization of human normal and NF1 neurofibroma Schwann cells.Is there a role for early chemotherapy in the management of pituitary adenomas?Molecular characterization reveals NF1 deletions and FGFR1-activating mutations in a pediatric spinal oligodendroglioma.Prospect and progress of oncolytic viruses for treating peripheral nerve sheath tumors.Synergistic Interplay between Curcumin and Polyphenol-Rich Foods in the Mediterranean Diet: Therapeutic Prospects for Neurofibromatosis 1 Patients.Modification of pedicle lengthening through perforator transposition in free anterolateral thigh flaps with pedicle size discrepancy: A case report.Generation of Noninvasive, Quantifiable, Orthotopic Animal Models for NF2-Associated Schwannoma and Meningioma.Neurofibromatosis: part 2--clinical management.Neurodevelopment. "RASopathic" astrocytes constrain neural plasticity.Neurofibromatosis type I and multiple myeloma coexistence: A possible link?Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1Quick and sustained clinical response to MEK inhibitor I in a NF1 patient with neurofibromas
P2860
Q27334571-D95CA496-C5F5-41A3-A7AF-E82E60588118Q29616044-AD572AB9-2EC3-47AD-B0FB-0BC7E58898DCQ34412515-664C0FBE-34EC-4669-874B-887F3C52F7B8Q36787769-60E87821-32AB-4C20-AE51-EBEA9CCDE5D9Q37641630-36CF5CCD-8050-41CF-A17D-B02A3EA21A2EQ38151546-F7D2FF85-2101-42F0-B89C-3167341F7CFCQ38635798-4F10523B-7AE9-4C2F-8656-A5346F4950C3Q38713914-40922FC6-B676-470A-BCA9-3D0C98E98063Q38746881-0C3A8BD0-CEF8-4EE4-BFBB-5981FFC4A808Q38815400-B2C43102-73D0-4051-BFA8-2A11E130DF38Q39174603-BC706822-1FC9-44E5-A045-2CF08F8CBA66Q40465319-2BBDAB49-65B1-4B3C-AB58-402B2342A96DQ42340618-61CC8C30-DA1A-47E0-9C91-D1233B63D990Q47197942-A0233B77-BA2D-4427-9D7B-FD04FDEE2F06Q51721478-24310435-F495-4E44-BA5C-BE3C8ADB529EQ53464959-C24DA9CF-5550-4C61-86D9-5DE3399D5A4AQ53514814-A66D8DDE-5A03-4E44-82B4-CB0CECE96598Q54940448-F85A8F9F-2E30-4599-ADE1-F554D2C4F392Q57298266-5D32C6C7-A8F7-4E45-9D18-77A6CCF80D78Q58699185-12336251-C413-4BF5-A15D-86081E6DCCF2
P2860
Advances in the treatment of neurofibromatosis-associated tumours.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Advances in the treatment of neurofibromatosis-associated tumours.
@en
type
label
Advances in the treatment of neurofibromatosis-associated tumours.
@en
prefLabel
Advances in the treatment of neurofibromatosis-associated tumours.
@en
P2860
P1476
Advances in the treatment of neurofibromatosis-associated tumours
@en
P2093
Andrew L Lin
P2860
P304
P356
10.1038/NRCLINONC.2013.144
P407
P577
2013-08-13T00:00:00Z